Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03926520
NA

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Sponsor: Brent Forester

View on ClinicalTrials.gov

Summary

This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will also determine the tolerability/safety outcomes of ECT+UC.

Official title: Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2021-01-28

Completion Date

2025-05-31

Last Updated

2024-06-03

Healthy Volunteers

No

Interventions

DEVICE

Electroconvulsive Therapy (ECT)

Stimulus method of delivery will be RUL electrode placement, and ultra-brief (UB) pulse width (0.25-0.37ms). At the first ECT session, seizure threshold (ST) will be determined by titration with the empirical dose titration method and subsequent treatments will be approximately 6 times the ST. Following other NIMH sponsored multicenter ECT studies (PRIDE, U01 MH055495), stimulus settings will be adjusted as needed during the ECT course based on seizure quality and treatment efficacy. Participants will be administered anesthesia.

Locations (5)

Emory Healthcare

Atlanta, Georgia, United States

McLean Hospital

Belmont, Massachusetts, United States

Pine Rest Christian Mental Health Services

Grand Rapids, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Northwell Health

Glen Oaks, New York, United States